Clinical Trials Browser

OTHER × Glioblastoma × sacituzumab govitecan × Clear all

NCT04559230 2025-08-05

Sacituzumab Govitecan in Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT03995706 2024-09-04

Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0

Phase EARLY_PHASE1 Completed

Glioblastoma